Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4833-4846

  Tan, Gek San ^a,b   Lim, Kiat Hon ^b   Tan, Hwee Tong ^a   Khoo, May Lee ^b   Tan, Sze Huey ^c   Toh, Han Chong ^c   Ching Ming Chung, Maxey ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

2D DIGE; Hepatocellular carcinoma; prognostic biomarkers; recurrence; relapse

Indexed keywords

ARGININOSUCCINATE SYNTHASE; HEAT SHOCK PROTEIN 70; TRANSKETOLASE; URIDINE TRIPHOSPHATE GLUCOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VALIDATION STUDY; CARCINOMA, HEPATOCELLULAR; GENETICS; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; NEOPLASM METASTASIS; PROCEDURES; PROGNOSIS; RECURRENT DISEASE; TISSUE MICROARRAY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ARGININOSUCCINATE SYNTHASE; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROTEOMICS; RECURRENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TISSUE ARRAY ANALYSIS; TRANSKETOLASE; UTP-GLUCOSE-1-PHOSPHATE URIDYLYLTRANSFERASE;

EID: 84908876975     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500229n     Document Type: Article

References (38)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics Ca-Cancer J. Clin. 2011, 61, 69-90
2. Bosch, F. X.; Ribes, J.; Cleries, R.; Diaz, M. Epidemiology of hepatocellular carcinoma Clin. Liver Dis. 2005, 9, 191-211
3. Wong, R.; Frenette, C. Updates in the management of hepatocellular carcinoma Gastroenterol. Hepatol. 2011, 7, 16-24
4. Chang, S. K.; Hlaing, W. W.; Yu, R. Q.; Lee, T. W.; Ganpathi, I. S.; Madhavan, K. K. Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection Singapore Med. J. 2012, 53, 32-35
5. Kanamori, H.; Kawakami, T.; Effendi, K.; Yamazaki, K.; Mori, T.; Ebinuma, H.; Masugi, Y.; Du, W.; Nagasaka, K.; Ogiwara, A.; Kyono, Y.; Tanabe, M.; Saito, H.; Hibi, T.; Sakamoto, M. Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma Oncology 2011, 80, 406-415
6. Cheng, J.; Xie, H. Y.; Xu, X.; Wu, J.; Wei, X.; Su, R.; Zhang, W.; Lv, Z.; Zheng, S.; Zhou, L. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma Cancer Lett. 2011, 310, 35-45
7. Lee, J. S.; Chu, I. S.; Heo, J.; Calvisi, D. F.; Sun, Z.; Roskams, T.; Durnez, A.; Demetris, A. J.; Thorgeirsson, S. S. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 2004, 40, 667-676
8. Yokoo, H.; Kondo, T.; Okano, T.; Nakanishi, K.; Sakamoto, M.; Kosuge, T.; Todo, S.; Hirohashi, S. Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery Cancer Sci. 2007, 98, 665-673
9. Mortz, E.; Krogh, T. N.; Vorum, H.; Gorg, A. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis Proteomics 2001, 1, 1359-1363
10. Liang, R. C.; Neo, J. C.; Lo, S. L.; Tan, G. S.; Seow, T. K.; Chung, M. C. Proteome database of hepatocellular carcinoma J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2002, 771, 303-328
11. Ren, F. Y.; Piao, X. X.; Jin, A. L. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma World J. Gastroenterol. 2006, 12, 4656-4659
12. Shirabe, K.; Takenaka, K.; Gion, T.; Shimada, M.; Fujiwara, Y.; Sugimachi, K. Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection J. Surg. Oncol. 1997, 64, 143-146
13. Soresi, M.; Magliarisi, C.; Campagna, P.; Leto, G.; Bonfissuto, G.; Riili, A.; Carroccio, A.; Sesti, R.; Tripi, S.; Montalto, G. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma Anticancer Res. 2003, 23, 1747-1753
14. Ciocca, D. R.; Calderwood, S. K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications Cell Stress Chaperones 2005, 10, 86-103
15. Shin, E.; Ryu, H. S.; Kim, S. H.; Jung, H.; Jang, J. J.; Lee, K. The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma J. Hepatobiliary Pancreatic Sci. 2011, 18, 544-550
16. Chuma, M.; Sakamoto, M.; Yamazaki, K.; Ohta, T.; Ohki, M.; Asaka, M.; Hirohashi, S. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma Hepatology 2003, 37, 198-207
17. Di Tommaso, L.; Destro, A.; Seok, J. Y.; Balladore, E.; Terracciano, L.; Sangiovanni, A.; Iavarone, M.; Colombo, M.; Jang, J. J.; Yu, E.; Jin, S. Y.; Morenghi, E.; Park, Y. N.; Roncalli, M. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma J. Hepatol. 2009, 50, 746-754
18. Luk, J. M.; Lam, C. T.; Siu, A. F.; Lam, B. Y.; Ng, I. O.; Hu, M. Y.; Che, C. M.; Fan, S. T. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values Proteomics 2006, 6, 1049-1057
19. Guo, F.; Rocha, K.; Bali, P.; Pranpat, M.; Fiskus, W.; Boyapalle, S.; Kumaraswamy, S.; Balasis, M.; Greedy, B.; Armitage, E. S.; Lawrence, N.; Bhalla, K. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin Cancer Res. 2005, 65, 10536-10544
20. Nylandsted, J.; Brand, K.; Jaattela, M. Heat shock protein 70 is required for the survival of cancer cells Ann. N.Y. Acad. Sci. 2000, 926, 122-125
21. Zhu, Q.; Xu, Y. M.; Wang, L. F.; Zhang, Y.; Wang, F.; Zhao, J.; Jia, L. T.; Zhang, W. G.; Yang, A. G. Heat shock protein 70 silencing enhances apoptosis inducing factor-mediated cell death in hepatocellular carcinoma HepG2 cells Cancer Biol. Ther. 2009, 8, 792-798
22. Zhuang, H.; Jiang, W.; Zhang, X.; Qiu, F.; Gan, Z.; Cheng, W.; Zhang, J.; Guan, S.; Tang, B.; Huang, Q.; Wu, X.; Huang, X.; Hu, Q.; Lu, M.; Hua, Z. C. Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions J. Mol. Med. 2013, 91, 219-235
23. Li, H.; Sui, C.; Kong, F.; Zhang, H.; Liu, J.; Dong, M. Expression of HSP70 and JNK-related proteins in human liver cancer: Potential effects on clinical outcome Dig. Liver Dis. 2007, 39, 663-670
24. Goloudina, A. R.; Demidov, O. N.; Garrido, C. Inhibition of HSP70: a challenging anti-cancer strategy Cancer Lett. 2012, 325, 117-124
25. Jego, G.; Hazoume, A.; Seigneuric, R.; Garrido, C. Targeting heat shock proteins in cancer Cancer Lett. 2013, 332, 275-285
26. Kobayashi, E.; Masuda, M.; Nakayama, R.; Ichikawa, H.; Satow, R.; Shitashige, M.; Honda, K.; Yamaguchi, U.; Shoji, A.; Tochigi, N.; Morioka, H.; Toyama, Y.; Hirohashi, S.; Kawai, A.; Yamada, T. Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma Mol. Cancer Ther. 2010, 9, 535-544
27. Delage, B.; Fennell, D. A.; Nicholson, L.; McNeish, I.; Lemoine, N. R.; Crook, T.; Szlosarek, P. W. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer Int. J. Cancer 2010, 126, 2762-2772
28. Ensor, C. M.; Holtsberg, F. W.; Bomalaski, J. S.; Clark, M. A. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo Cancer Res. 2002, 62, 5443-5450
29. Dillon, B. J.; Prieto, V. G.; Curley, S. A.; Ensor, C. M.; Holtsberg, F. W.; Bomalaski, J. S.; Clark, M. A. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation Cancer 2004, 100, 826-833
30. Bi, X.; Lin, Q.; Foo, T. W.; Joshi, S.; You, T.; Shen, H. M.; Ong, C. N.; Cheah, P. Y.; Eu, K. W.; Hew, C. L. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis Mol. Cell. Proteomics 2006, 5, 1119-1130
31. Warburg, O. On the origin of cancer cells Science 1956, 123, 309-314
32. Ortega, A. D.; Sanchez-Arago, M.; Giner-Sanchez, D.; Sanchez-Cenizo, L.; Willers, I.; Cuezva, J. M. Glucose avidity of carcinomas Cancer Lett. 2009, 276, 125-135
33. Vander Heiden, M. G.; Cantley, L. C.; Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 2009, 324, 1029-1033
34. Kondoh, H. Cellular life span and the Warburg effect Exp. Cell Res. 2008, 314, 1923-1928
35. Yeluri, S.; Madhok, B.; Prasad, K. R.; Quirke, P.; Jayne, D. G. Cancers craving for sugar: an opportunity for clinical exploitation J. Cancer Res. Clin. Oncol. 2009, 135, 867-877
36. Chen, Z.; Lu, W.; Garcia-Prieto, C.; Huang, P. The Warburg effect and its cancer therapeutic implications J. Bioenerg. Biomembr. 2007, 39, 267-274
37. Pelicano, H.; Martin, D. S.; Xu, R. H.; Huang, P. Glycolysis inhibition for anticancer treatment Oncogene 2006, 25, 4633-4646
38. Scatena, R.; Bottoni, P.; Pontoglio, A.; Mastrototaro, L.; Giardina, B. Glycolytic enzyme inhibitors in cancer treatment Expert Opin. Investig. Drugs 2008, 17, 1533-1545